In Dec 2018, HUL announced the merger of GSK Consumer Healthcare with the company.Under the terms of the merger deal, which was completed in 2020, HUL acquired the Horlicks brand for India from GSK for Rs 3,045 crore. Additionally, GSKCH’s other brands like Boost, Maltova and Viva also moved to HUL’s product portfolio.
HUL said that it will appeal the order. “Further, the company has an indemnification right to recover the demand raised by the Income Tax department and will undertake necessary steps in furtherance of the same,” HUL said. It said that the tax demand will not have any significant financial implications at this stage.
#HUL #crore #notice #TDS #dispute #GSK #deal #Times #India